Diagnosis Code C67.5
Information for Medical Professionals
The diagnosis code C67.5 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)
- 656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
- 657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
- 658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC
- 659 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC
- 660 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC
- 661 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 188.5 - Mal neo bladder neck
- Malignant tumor of bladder neck
- Neoplasm of urinary bladder neck
- Primary malignant neoplasm of urinary bladder neck
Index of Diseases and Injuries
References found for the code C67.5 in the Index of Diseases and Injuries:
- Inclusion Terms: Inclusion terms
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Malignant neoplasm of internal urethral orifice
Table of Neoplasms
The code C67.5 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
The Tabular must be reviewed for the complete diagnosis code.
|»urethra, urethral (gland)|
Information for Patients
The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.
- Blood in your urine
- A frequent urge to urinate
- Pain when you urinate
- Low back pain
Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.
Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.
NIH: National Cancer Institute
- Bladder biopsy (Medical Encyclopedia)
- Bladder cancer (Medical Encyclopedia)
- Cancer - renal pelvis or ureter (Medical Encyclopedia)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)
Bladder cancer Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply without control or order. The bladder is a hollow, muscular organ in the lower abdomen that stores urine until it is ready to be excreted from the body. The most common type of bladder cancer begins in cells lining the inside of the bladder and is called transitional cell carcinoma (TCC).Bladder cancer may cause blood in the urine, pain during urination, frequent urination, or the feeling that one needs to urinate without results. These signs and symptoms are not specific to bladder cancer, however. They also can be caused by noncancerous conditions such as infections.